ArticleJournal of Alzheimer's disease : JAD2026
Color-modulated olfactory testing using RAPPIT: An innovative tool for early detection of cognitive decline.
Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundOlfactory and visual processing are sensitive biomarkers for cognitive impairment; however, unimodal assessments may fail to capture early deficits in higher order cognitive integration. When sensory cues are mismatched, multisensory processing induces crossmodal conflict that requires inhibitory control, which is particularly vulnerable in early neurodegeneration.ObjectiveWe developed RAPPIT (Rapid, massively APPlicable Identification Test), a color-modulated olfactory test to assess multisensory interference as an early marker of cognitive decline.MethodsRAPPIT includes 16 physically presented odors, with a digital application for task control and response recording. Answer options are displayed on color backgrounds derived from the MONEX-40 color profile, either congruent or incongruent with the presented odors. A total of 163 participants from the German population completed the assessment. Odor identification accuracy, effects of color congruence (ΔE00), associations with cognitive performance (Montreal Cognitive Assessment, MoCA), hedonic ratings, and depressive symptoms were analyzed.ResultsOdor identification declined with age. Participants aged ≥ 60 years, a group at increased risk for neurodegenerative disorders including Alzheimer's disease, showed reduced performance under incongruent conditions. Performance exhibited a non-linear relationship with color difference (ΔE00), declining at mid-range values. Accuracy was significantly associated with MoCA scores. Hedonic ratings varied with color cues, while no associations were found with depressive symptoms.ConclusionsThese findings demonstrate that differences between congruent and incongruent odor-color conditions capture cognitively relevant interference effects beyond unimodal olfactory or visual performance, supporting the utility of this approach for early detection of cognitive impairment in older adults, in clinical and home settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.